Ledger.Open graph →
SEC Form D · filed August 29, 2022

Kolon TissueGene, Inc

Offering
$29.6M
Sold
$29.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ROCKVILLE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Charles S. Nye · Rockville, MDExecSung S. Han · Rockville, MDExec · DirectorMoon Jong S. Noh · Rockville, MDExec · DirectorYoung J. Kim · Rockville, MDExecSoon-Wook J. Kweon · Rockville, MDExecYonggyun J. Jeong · Rockville, MDExecJung In S. Kim · Rockville, MDExec · DirectorSun Jin J. Kim · Rockville, MDExecJangik S. Lee · Rockville, MDDirectorShalabh Gupta · Los Altos, CAExecScott Niewohner · Herman, NEExec · DirectorJohn Ryan · Los Altos, CAExecKostas Nasis · Haddonfield, NJExecWesley Gottesman · Haddonfield, NJExecJohn Townsend · Los Altos, CAExecThomas Ferguson · Bloomington, INExec · DirectorGaurav Aggarwal · Los Altos, CADirectorDeborah C. Spalding · Wilton, CTExec · DirectorDon Listwin · Woodside, CAExecCarolyn Maury · Scottsdale, AZExecCharles Maury · Scottsdale, AZExecDaniel Steinberg · Austin, TXDirectorSpencer C. Tall · PALO ALTO, CAExec · DirectorAllegis X Management, LLC · PALO ALTO, CAExec · DirectorAmy Batra · Doylestown, PAExecSanjay Batra · Doylestown, PAExecLaurence Rongvaux · Luxembourg, LuxembourgExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗